Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × CX 3543 × Clear all

NCT00780663 2011-06-15

Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

Phase 2 Completed

Carcinoid Tumor, Neuroendocrine Tumors